Abeona Therapeutics opens The Elisa Linton Center for Rare Disease Therapies

Abeona Therapeutics Inc. (Nasdaq:ABEO) has opened The Elisa Linton Center for Rare Disease Therapies, a 6,000-square-foot commercial manufacturing facility for gene and cell therapies in Cleveland.

The clinical-stage biopharmaceutical company, which focuses on developing novel gene and cell therapies for life-threatening rare diseases, announced last year it would construct the facility in the hopes of creating life-saving treatments out of its own manufacturing facility.

Click here to read the complete article.
Story excerpt provided by Crain’s Cleveland Business. Written by Lydia Coutre. Originally published June 11, 2018.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

%d bloggers like this: